AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3929876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31337448 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation (27.5 g whey protein/d, about 2000 kJ/d)
Number of subjects: 165
Study 31337448 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic placebo-products (< 1.5 g protein/d)
Number of subjects: 165
Study 31337448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Protein and Placebo)
Number of subjects: 165
Study 30430861 — intervention group
Group type: EXPERIMENTAL
Intervention: Full contingency table with causal explanation
Number of subjects: 245
Study 30430861 — intervention group
Group type: COMPARATOR
Intervention: Basic refutation of multivitamin efficacy
Number of subjects: 245
Study 26693964 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR intervention (Supporting Treatment Adherence Regimens)
Number of subjects: 50
Study 26693964 — intervention group
Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 50
Study 24682210 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 85
Study 24682210 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 85
Study 22198375 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 nights of sleep restriction (9, 8, 7, 6, or 5 h time in bed)
Number of subjects: 88
Study 22198375 — intervention group
Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (6 h time in bed)
Number of subjects: 88
Study 22198375 — intervention group
Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (5 h time in bed)
Number of subjects: 88
Study 22198375 — intervention group
Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (7 h time in bed)
Number of subjects: 88
Study 22198375 — intervention group
Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (8 h time in bed)
Number of subjects: 88
Study 22198375 — intervention group
Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (9 h time in bed)
Number of subjects: 88
Study 20580358 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hCG (250 μg)
Number of subjects: 119
Study 20580358 — intervention group
Group type: COMPARATOR
Intervention: Urinary-derived hCG (10,000 IU)
Number of subjects: 119
Study 17673609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant (250 mg/month)
Number of subjects: 0
Study 17673609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant high-dose (500 mg/month)
Number of subjects: 0
Study 17673609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant loading-dose regimen (250 mg/month plus 500 mg on day 0 and 250 mg on day 14 of month 1)
Number of subjects: 0
Study 16051400 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose of pertussis vaccine
Number of subjects: 542
Study 16051400 — intervention group
Group type: COMPARATOR
Intervention: Third dose of pertussis vaccine
Number of subjects: 542
Study 11966926 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival water irrigation 2x daily
Number of subjects: 52
Study 11966926 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaling and scaling and root planing (Control)
Number of subjects: 52
Study 10080558 — intervention group
Group type: EXPERIMENTAL
Intervention: Fananserin 250 mg b.i.d. over 28 days (with an 8-day escalation)
Number of subjects: 97
Study 10080558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 7593920 — intervention group
Group type: EXPERIMENTAL
Intervention: Masker in-phase and signal in-phase (NoSo)
Number of subjects: 0
Study 7593920 — intervention group
Group type: EXPERIMENTAL
Intervention: Masker in-phase and signal pi rad out-of-phase (NoS pi)
Number of subjects: 0
Study 7593920 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-center-frequency condition (NoS pi)
Number of subjects: 0
Study 7593920 — intervention group
Group type: COMPARATOR
Intervention: Gaussian noise masker
Number of subjects: 0
Study 7593920 — intervention group
Group type: COMPARATOR
Intervention: Informational masker comprised of eight randomly chosen eight-tone bursts centered at 1000 Hz
Number of subjects: 0
Study 1965456 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-AIDS medical diagnosis
Number of subjects: 600
Study 1965456 — intervention group
Group type: EXPERIMENTAL
Intervention: DNR orders
Number of subjects: 600
Study 1965456 — intervention group
Group type: COMPARATOR
Intervention: AIDS-related risk factors (gay v. IVDU)
Number of subjects: 600
Study 1965456 — intervention group
Group type: COMPARATOR
Intervention: Medical diagnosis (AIDS v. non-AIDS)
Number of subjects: 600
Study 1965456 — intervention group
Group type: COMPARATOR
Intervention: DNR order v. no DNR order
Number of subjects: 600
Study 7018502 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol (15, 20, and 30 g/day)
Number of subjects: 65
Study 7018502 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate (2 g/day)
Number of subjects: 65
Study 7018502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 30478597 — intervention group
Group type: EXPERIMENTAL
Intervention: Email method
Number of subjects: 1168
Study 30478597 — intervention group
Group type: COMPARATOR
Intervention: Telephone method
Number of subjects: 1168
Study 30478597 — intervention group
Group type: COMPARATOR
Intervention: Postal method
Number of subjects: 1168
Study 30478597 — intervention group
Group type: COMPARATOR
Intervention: Public hospitals
Number of subjects: 1168
Study 30478597 — intervention group
Group type: COMPARATOR
Intervention: Email compared to Telephone
Number of subjects: 1168
Study 29231482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Diji (SP 8)
Number of subjects: 200
Study 29231482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Zusanli (ST 36)
Number of subjects: 200
Study 29231482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Taichong (LR 3)
Number of subjects: 200
Study 29231482 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical blockage anesthesia with lidocaine
Number of subjects: 200
Study 29231482 — intervention group
Group type: COMPARATOR
Intervention: Blank group (without analgesia)
Number of subjects: 200
Study 25605812 — intervention group
Group type: EXPERIMENTAL
Intervention: DIAMOS (Diabetes Motivation Strengthening)
Number of subjects: 214
Study 25605812 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - diabetes education
Number of subjects: 214
Study 23314693 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) applied at the dorsolateral prefrontal cortex (DLPFC) bilaterally
Number of subjects: 50
Study 23314693 — intervention group
Group type: COMPARATOR
Intervention: tACS (transcranial alternating current stimulation) applied at the dorsolateral prefrontal cortex (DLPFC) bilaterally
Number of subjects: 50
Study 22423411 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment alone
Number of subjects: 34
Study 22423411 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment combined with orthognathic surgery
Number of subjects: 34
Study 22423411 — intervention group
Group type: COMPARATOR
Intervention: Control group (orthodontic treatment alone)
Number of subjects: 34
Study 19521294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg/kg
Number of subjects: 80
Study 19521294 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80
Study 18378947 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin-down posture (n = 259)
Number of subjects: 515
Study 18378947 — intervention group
Group type: EXPERIMENTAL
Intervention: Nectar-thick liquids (n = 133)
Number of subjects: 515
Study 18378947 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-thick liquids (n = 123)
Number of subjects: 515
Study 18378947 — intervention group
Group type: COMPARATOR
Intervention: Thickened liquids (nectar or honey)
Number of subjects: 515
Study 18378947 — intervention group
Group type: COMPARATOR
Intervention: Chin-down posture
Number of subjects: 515
Study 18378947 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickened liquids
Number of subjects: 515
Study 16287352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (G1) - 6RM sets in set repetition format for 5 exercises
Number of subjects: 0
Study 16287352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (G2) - 6RM sets in set repetition format for 6 exercises
Number of subjects: 0
Study 12297762 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (750 mg)
Number of subjects: 0
Study 12297762 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate (500 mg)
Number of subjects: 0
Study 12297762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10405838 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhydrated Haemoccult II
Number of subjects: 0
Study 10405838 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects aged > or = 65
Number of subjects: 0
Study 10405838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancers of the distal colon
Number of subjects: 0
Study 7480761 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-PEI group (single TACE session followed by PEI)
Number of subjects: 53
Study 7480761 — intervention group
Group type: COMPARATOR
Intervention: TACE group (two to five TACE sessions)
Number of subjects: 53
Study 2148357 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (5 to 40 mg/day)
Number of subjects: 10
Study 2148357 — intervention group
Group type: COMPARATOR
Intervention: Control group (22 controls and 17 uninephrectomized donors)
Number of subjects: 10
Study 7305427 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 111
Study 7305427 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 111
Study 7305427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 31996583 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 862
Study 31996583 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy followed by total mesorectal excision
Number of subjects: 862
Study 30747567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (1 hour session, 2 times per week for 12 weeks)
Number of subjects: 52
Study 30747567 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study 29931409 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg three times daily
Number of subjects: 40
Study 29931409 — intervention group
Group type: COMPARATOR
Intervention: Control (FOLFOX-4 regimen only)
Number of subjects: 40
Study 27608620 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weeks of physical training
Number of subjects: 54
Study 27608620 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weeks of cognitive training
Number of subjects: 54
Study 27608620 — intervention group
Group type: COMPARATOR
Intervention: Matched wait-list control condition
Number of subjects: 54
Study 27608620 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported lifestyle activities
Number of subjects: 54
Study 24274808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored decision aid (DA)
Number of subjects: 0
Study 24274808 — intervention group
Group type: COMPARATOR
Intervention: Nontailored information about prostate cancer screening (control)
Number of subjects: 0
Study 22424001 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention (experimental group)
Number of subjects: 34
Study 22424001 — intervention group
Group type: COMPARATOR
Intervention: Routine practice (control group)
Number of subjects: 34
Study 20428949 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 196
Study 20428949 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 4 mg
Number of subjects: 196
Study 20428949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 20428949 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg and 4 mg
Number of subjects: 196
Study 18522689 — intervention group
Group type: EXPERIMENTAL
Intervention: modafinil 400 mg
Number of subjects: 53
Study 18522689 — intervention group
Group type: EXPERIMENTAL
Intervention: dextroamphetamine 20 mg
Number of subjects: 53
Study 18522689 — intervention group
Group type: EXPERIMENTAL
Intervention: caffeine 600 mg
Number of subjects: 53
Study 18522689 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 53
Study 16706812 — intervention group
Group type: EXPERIMENTAL
Intervention: Photic stimulation for 25 min
Number of subjects: 40
Study 16706812 — intervention group
Group type: COMPARATOR
Intervention: Control group (no photic stimulation)
Number of subjects: 40
Study 16706812 — intervention group
Group type: EXPERIMENTAL
Intervention: Photic stimulation
Number of subjects: 40
Study 12943873 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 150 mg
Number of subjects: 161
Study 12943873 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 300 mg
Number of subjects: 161
Study 12943873 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 600 mg
Number of subjects: 161
Study 12943873 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 900 mg
Number of subjects: 161
Study 12943873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 10384232 — intervention group
Group type: EXPERIMENTAL
Intervention: Vehicle speed change and relative head restraint position
Number of subjects: 0
Study 10384232 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated posture measures
Number of subjects: 0
Study 8763975 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 28
Study 8763975 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 28
Study 1707149 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate suspension
Number of subjects: 14
Study 1707149 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine syrup plus kaolin-pectin
Number of subjects: 14
Study 1707149 — intervention group
Group type: COMPARATOR
Intervention: Control group (retrospective review of 15 patients without mouth-coating rinse)
Number of subjects: 14
Study 6809324 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hyperalimentation (IVH)
Number of subjects: 49
Study 6809324 — intervention group
Group type: COMPARATOR
Intervention: No intravenous hyperalimentation (Control group)
Number of subjects: 49
Study 31617992 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam plus amikacin (Group A)
Number of subjects: 164
Study 31617992 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (Group B)
Number of subjects: 164
Study 28641027 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical-practical course in Spirituality and Health (S/H)
Number of subjects: 49
Study 28641027 — intervention group
Group type: COMPARATOR
Intervention: Control Group (waiting list)
Number of subjects: 49
Study 25725183 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 5mg, t.d.s.
Number of subjects: 100
Study 25725183 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 2mg, b.i.d.
Number of subjects: 100
Study 23311732 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-178882 300 mg single-dose
Number of subjects: 0
Study 23311732 — intervention group
Group type: COMPARATOR
Intervention: ACT-178882 300 or 600 mg multiple-dose
Number of subjects: 0
Study 23311732 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-178882 multiple-dose
Number of subjects: 0
Study 21333466 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (80 mg/day)
Number of subjects: 21
Study 21333466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 19732431 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0
Study 19732431 — intervention group
Group type: COMPARATOR
Intervention: Small-incision cholecystectomy
Number of subjects: 0
Study 17643781 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoprotection of total parenteral nutrition (TPN)
Number of subjects: 0
Study 17643781 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) without photoprotection
Number of subjects: 0
Study 15753144 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg RRR‐alpha‐tocopheryl acetate
Number of subjects: 24
Study 15753144 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg all‐rac‐alpha‐tocopheryl acetate
Number of subjects: 24
Study 11727359 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - 0.625 mg 17 beta‐estradiol plus 10 mg progestin, followed for 48 months
Number of subjects: 186
Study 11727359 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control group)
Number of subjects: 186
Study 9629815 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based smoking cessation intervention delivered by midwives during routine antenatal and postnatal care
Number of subjects: 220
Study 9629815 — intervention group
Group type: COMPARATOR
Intervention: Usual care (historical control group)
Number of subjects: 220
Study 9629815 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based smoking cessation intervention
Number of subjects: 220
Study 8163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 18
Study 8163135 — intervention group
Group type: COMPARATOR
Intervention: Standard biopsy forceps
Number of subjects: 18
Study 8163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumbo biopsy specimens oriented with stereomicroscopy
Number of subjects: 18
Study 8163135 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumbo biopsy specimens oriented with naked eye
Number of subjects: 18
Study 8163135 — intervention group
Group type: COMPARATOR
Intervention: Standard biopsy specimens (irrespective of orientation)
Number of subjects: 18
Study 3367677 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy helium-neon (HeNe) laser irradiation (0.9 mW) for 60 seconds daily over a 5-day period.
Number of subjects: 0
Study 3367677 — intervention group
Group type: COMPARATOR
Intervention: Control cultures (not irradiated)
Number of subjects: 0
Study 31236402 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter inserted into the anterior region of the TPVS (group A)
Number of subjects: 50
Study 31236402 — intervention group
Group type: COMPARATOR
Intervention: Catheter inserted into the posterior region of the TPVS (group P)
Number of subjects: 50
Study 31236402 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 28260640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (not specified)
Number of subjects: 762
Study 28260640 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 762
Study 28260640 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's acceptance of IPV
Number of subjects: 762
Study 28260640 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's attitudes towards IPV
Number of subjects: 762
Study 28260640 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's first report of IPV in Waves 2 or 3
Number of subjects: 762
Study 26440227 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)/90 mg twice‐daily maintenance dose (MD)
Number of subjects: 40
Study 26440227 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/75 mg once‐daily MD
Number of subjects: 40
Study 26440227 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40
Study 26440227 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study 23121074 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling intervention (four face-to-face sessions and one telephone session)
Number of subjects: 219
Study 23121074 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counselling intervention)
Number of subjects: 219
Study 22220459 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital glaucoma patients
Number of subjects: 27
Study 22220459 — intervention group
Group type: COMPARATOR
Intervention: Antiglaucomatous operation
Number of subjects: 27
Study 19185649 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 65
Study 19185649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 17003097 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothyroid group (HO)
Number of subjects: 21
Study 15250768 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical transillumination spectroscopy
Number of subjects: 92
Study 11206241 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin test (ST) with a panel of aeroallergens plus tobacco extract
Number of subjects: 170
Study 9522323 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 2.5 mg
Number of subjects: 123
Study 9522323 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 5 mg
Number of subjects: 123
Study 9522323 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 10 mg
Number of subjects: 123
Study 9522323 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 15 mg
Number of subjects: 123
Study 9522323 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 123
Study 9522323 — intervention group
Group type: COMPARATOR
Intervention: Women in the highest quartile of bone turnover at baseline
Number of subjects: 123
Study 7702336 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate 320
Number of subjects: 38
Study 7702336 — intervention group
Group type: COMPARATOR
Intervention: Iopromide 370
Number of subjects: 38
Study 2889313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 3
Study 2889313 — intervention group
Group type: COMPARATOR
Intervention: Internal intercostal nerve block
Number of subjects: 3
Study 2889313 — intervention group
Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 3
Study 29359385 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused ultrasound device (UltraShape) treatment on one thigh
Number of subjects: 14